News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
107 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (24223)
Month
January (2882)
February (2030)
March (1769)
April (2200)
May (2664)
June (3161)
July (3087)
August (3800)
September (4259)
October (5135)
November (4629)
December (3503)
Day
1 (3)
2 (126)
3 (109)
4 (46)
5 (53)
6 (70)
7 (2)
8 (3)
9 (93)
10 (97)
11 (67)
12 (115)
13 (23)
16 (45)
17 (61)
18 (207)
19 (143)
20 (33)
21 (1)
22 (1)
23 (48)
24 (107)
25 (87)
26 (242)
27 (149)
29 (6)
30 (263)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
16
17
18
19
20
21
22
23
24
25
26
27
29
30
What Qualities of a Good Mentor to Look For
Moving forward in your career requires having a great mentor. Here are some qualities of a good mentor that you should look for before choosing one for yourself.
April 24, 2018
·
3 min read
·
Porschia Parker
Drug Development
Tocagen Granted ApolloBio Greater China Rights of Immunotherapy Candidate for $127 Million
Tocagen Inc. licensed its Phase III stage candidate Toca 511 & Toca FC to ApolloBio .
April 24, 2018
·
1 min read
Business
Xellia Pharmaceuticals Appoints Craig Boyd as President, Xellia US as it Expands its Commercial Organization in Preparation for the Launch of its Value-Added Anti-Infective Drug Products
Xellia Pharmaceuticals announced that it has appointed Craig Boyd to the new leadership role of President, Xellia US.
April 24, 2018
·
4 min read
Business
Synpromics awarded Innovate UK grant to evaluate its inducible promoter platform in collaboration with Lonza Pharma & Biotech
Synpromics Ltd announces a partnership with Lonza Pharma & Biotech to further develop its inducible promoter system and improve manufacturing of biopharmaceuticals.
April 24, 2018
·
4 min read
Business
First-Quarter Figures: Sartorius Starts off Fiscal 2018 Successfully
Sartorius looks back on a successful first quarter 2018.
April 24, 2018
·
8 min read
FDA
Medtronic IN.PACT(TM) Admiral(TM) Drug Coated Balloon Receives FDA Approval to Treat Long SFA Lesions
New Indication Expands DCB Treatment for Patients with SFA Lesions Up to 360mm
April 24, 2018
·
4 min read
Business
Hamilton Robotics and Coastal Genomics Introduce Scalable Automated NGS Library Preparation and Electrophoretic System for Significant Clinical Efficiencies and Savings
Automated gel electrophoresis combined with liquid handling workstations vastly improves time and efficiency for sequencing and associated quality control
April 24, 2018
·
3 min read
FDA
Abeona Announces FDA Grants RMAT Designation to ABO-102 Gene Therapy in MPS IIIA
First Gene Therapy Using AAV Approach Granted Regenerative Medicine Advanced Therapy Designation
April 24, 2018
·
3 min read
Drug Development
Paratek Pharmaceuticals Presents Data Supporting Potential Approval of Omadacycline for Treatment of Community-Acquired Bacterial Pneumonia Based on the EMA Guidelines at ECCMID
Paratek Pharmaceuticals, Inc. presented an analysis of data from the Company’s Phase 3 OPTIC study of omadacycline vs. moxifloxacin for the treatment of community-acquired bacterial pneumonia (CABP) using the European Medicines Agency (EMA) guidance for approval of new treatments for CABP.
April 24, 2018
·
6 min read
Drug Development
Paratek Pharmaceuticals Presents New Microbiology Efficacy Data of Oral-only Omadacycline Against the Most Common Pathogens Associated with Skin Infections
Paratek Pharmaceuticals, Inc. announced that an analysis of microbiology data from OASIS-2, its second Phase 3 study of omadacycline in acute skin infections, found that once-daily monotherapy with oral omadacycline is effective in treating frequently isolated pathogens associated with skin infections, including resistant Staphylococcus aureus (MRSA).
April 24, 2018
·
6 min read
1 of 11
Next